Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Gemcitabine Intravesical System Changes the Paradigm of Bladder Cancer Treatment

Summary by targetedonc.com
Joseph Jacob, MD, discusses the how the recent FDA approval of the gemcitabine intravesical system offers a radically different treatment approach for patients with bladder cancer.

2 Articles

TelegrafiTelegrafi
Lean Left

New Hope for Bladder Cancer Patients: Fda Approves Innovative Long-Acting Local Drug

New drug brings hope for bladder cancer patients who don't respond to standard treatments The US Food and Drug Administration (FDA) has approved the use of Inlexzo (gemcitabine intravesical system) for the treatment of adults with non-muscle invasive bladder cancer that has not affected the muscles but does not respond to standard therapy with the Bacillus Calmette-Guérin (BCG) vaccine. This is the case of so-called NMIBC (non-muscle invasive bl…

Read Full Article
targetedonc.comtargetedonc.com

Gemcitabine Intravesical System Changes the Paradigm of Bladder Cancer Treatment

Joseph Jacob, MD, discusses the how the recent FDA approval of the gemcitabine intravesical system offers a radically different treatment approach for patients with bladder cancer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

targetedonc.com broke the news in on Friday, September 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Healthcare icon

Healthcare

Albania icon

Albania

Maryland icon

Maryland

News
For You
SearchBlindspotLocal